EPO’s CRISPR hearing: day three, part two
Dr Emma Longland, HGF
The European Patent Office’s (EPO)’s Board of Appeal is currentlyundertaking oral hearings in a long-running patent dispute
involving the BroadInstitute, over the revocation of one of its CRISPR patents.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.